EquityZen Growth Technology Fund LLC - Series 247
Raised
$280K
Investors
16
Min Invest
$7,112
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 247 is a Delaware-formed pooled investment vehicle that raised $280K from 16 investors under Rule 506(b) and Section 3(c)(1) exemptions, with a $7K minimum investment. Filed May 2018 by EquityZen Advisors and Assure Fund Management II, this is one of approximately 1,891 series SPVs within the EquityZen pre-IPO investment platform.
This pre-IPO vehicle uses the standard 506(b)/3(c)(1) exemption combination typical of small pooled funds targeting accredited investors in private growth companies. The $7K minimum is accessible relative to institutional pre-IPO funds, and the $17.5K average investor commitment reflects EquityZen's retail-accessible model for fractional secondary market exposure.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Shriram Bhashyam
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
